IRF4 and lymphoma: The prognostic value of cell-cycle associated markers in disease-free survival and lymphoma related death has been investigated, and lymphoma associated transcription factor BCL-6, MUM1/IRF4 and MIB1/Ki-67 have been associated with a higher risk of disseminated disease.